- Adults
- Elderly
- People at high risk of STIs
- Men who have sex with men
- PrEP users
- Primary care
- Non-hospital health centre
- STD/STI clinic
- Chlamydia trachomatis
- Neisseria gonorrhoeae
- Syphilis
- Sexually transmitted infection
- Pharmacological intervention
- Antivirals
- PrEP-HIV
Central Data Repository
Explore the Central Data Repository: Use the filters and keyword search box on the left to find relevant studies. As you refine your search, the map and study list will automatically update to reflect your selections. Selecting a study from the list will provide detailed information about the specific study in question. A full legend can be found here
{content}
Study list
- Adults
- General population
- Elderly
- Hospital wide
- Emergency department
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Adults
- General population
- Hospital wide
- Non-hospital health centre
- Vaccination centre
- Monkeypox virus
- Monkeypox virus infection
- Blood sample
- Pharmacological intervention
- Vaccination
- MVA-BN
- Adults
- General population
- Hospital wide
- Outpatient clinic
- Monkeypox virus
- Monkeypox virus infection
- Adults
- People at high risk of STIs
- Men who have sex with men
- Hospital wide
- Outpatient clinic
- Monkeypox virus
- Monkeypox virus infection
- Adults
- Elderly
- Fragile population
- Paediatric
- Emergency department
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab
- Adults
- Elderly
- Fragile population
- Immunocompromised host
- Hospital wide
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Remdesivir
- Monoclonal antibodies
- Sotrovimab
- Adults
- Elderly
- Community
- Arbovirus
- Chikungunya virus
- Vector-borne
- Arboviral disease
- Vector-borne disease
- Post-infectious condition
- Adults
- General population
- Elderly
- Fragile population
- Immunocompromised host
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Remdesivir
- Molnupiravir
- Adults
- Fragile population
- Immunocompromised host
- Outpatient clinic
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Remdesivir
- Monoclonal antibodies
- Sotrovimab
- Molnupiravir
- Tixagevimab/Cilgavimab
- Casirivimab/Imdevimab
- Adults
- General population
- Elderly
- Hospital wide
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation